DOI QR코드

DOI QR Code

Designing a Molecular Diagnostic Laboratory for Testing Highly Pathogenic Viruses

고병원성 바이러스 검사를 위한 분자진단검사실 구축

  • Jung, Tae Won (Department of Office of Facility Planning, Samsung Medical Center) ;
  • Jung, Jaeyoung (Department of Laboratory Medicine, Samsung Medical Center) ;
  • Kim, Sunghyun (Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan) ;
  • Kim, Young-Kwon (Department of Health Sciences, The Graduate School of Konyang University)
  • 정태원 (삼성서울병원 미래병원추진단) ;
  • 정재영 (삼성서울병원 진단검사의학과) ;
  • 김성현 (부산가톨릭대학교 보건과학대학 임상병리학과) ;
  • 김영권 (건양대학교 보건복지대학원 보건학과)
  • Received : 2021.02.22
  • Accepted : 2021.03.14
  • Published : 2021.06.30

Abstract

The recent spread of novel and highly variant pathogenic viruses, including the coronavirus (SARS-CoV-2), has increased the demand for diagnostic testing for rapid confirmation. This has resulted in investigating the functional capability of each space, and preparing facility guidelines to secure the safety of medical technologists. During viral evaluations, there is a requirement of negative pressure facilities along with thread separation, during pre-treatment of samples and before nucleic acid amplification. Space composition therefore needs to be planned by considering unidirectional air flow. This classification of safety management facilities is designated as biosafety level 2, and personal protective equipment is placed accordingly. In case of handling dangerous materials, they need to be carried out of the biosafety cabinet, and sterilizers are required for suitable disposal of infectious agents. A common feature of domestic laboratories is maintenance of the sample pre-treatment space at a negative pressure of -2.5 Pa or less, and arranging separate pre-treatment and reagent preparation spaces during the test process. We believe that the data generated in this study is meaningful, and offers an efficient direction and detailed flow for separation of the inspection process and space functions. Moreover, this study introduces construction of the laboratory by applying the safety management standards.

최근 SARS-CoV-2를 포함한 신종 및 변종 고병원성 바이러스의 확산과 이를 확진하기 위한 진단검사의 수요가 증가함에 따라 분자유전검사실 구축 시 필요한 공간별 기능을 조사하고 임상병리사의 안전성 확보를 위한 시설 지침을 마련하고자 하였다. 검사과정 중 검체 전처리 및 핵산 증폭 전실 및 후실 분리와 함께 음압설비가 필요하며, 핵산 증폭 전 공간을 분리해 단방향 작업 흐름을 고려해 공간 구성을 하여야 한다. 검사 진행과정 중 검체 전처리, 핵산 증폭 전 단계에서 실 분리와 함께 음압시설이 필요하며, 공간구성은 핵산증폭 전실 및 후실 공간을 분리하고 검사진행 방향을 단방향 검사흐름(unidirectional work flow)을 고려하여 계획하여야 한다. 안전관리 시설은 생물학적 안전 기준 2등급으로 지정하고 그에 따른 안전보호구를 배치하고, 위험물을 취급하는 경우 생물학적 안전상자 내부에서 진행해야 하며, 전염성 오염물의 폐기를 위한 멸균기가 필요하다. 국내 분자유전검사실 사례의 공통점은 검체 전처리공간을 -2.5 Pa 이하의 음압으로 유지하고 있으며, 검사과정상 전처리와 시약준비 공간에 대해서는 다른 공간에서 진행하고 있었다. 본 연구는 검사과정의 세부흐름과 공간별 기능을 분리하고 안전관리 기준 적용한 검사실 구축 방향을 제시하였고, 임시시설과 결핵검사실을 변경하여 사용하는 사례를 소개함으로써 더욱 효율적인 방향을 모색할 수 있는 자료로 의의가 있다고 하겠다.

Keywords

References

  1. Coronaviridae study group of the international committee on taxonomy of viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5:536-544. https://doi.org/10.1038/s41564-020-0695-z
  2. CDC. Symptoms of coronavirus [Internet]. Washington: CDC; 2021 [cited 2021 Feb. 22]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html
  3. WHO. Coronavirus disease (COVID-19): how is it transmitted? [Internet]. Geneva: WHO; 2020 [cited 2020 July 9]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-covid-19-how-is-it-transmitted
  4. Sewell DL. Laboratory-associated infections and biosafety. Clin Microbiol Rev. 1995:389-405. https://doi.org/10.1128/CMR.8.3.389
  5. Korean Society for Laboratory Medicine. Guidelines the laboratory diagnosis of COVID-19 in Korea, 3rd ed [Internet]. Seoul: Korean Society for Laboratory Medicine; 2020 [cited 2020 Sep. 25]. Available from: https://www.kslm.org/rang_board/list.html?num=16622&code=covid19_press
  6. Kim SL, Yun YM, Kim IS, Song SH Woo HI, Lee KA, et al. Clinical pharmacogenetic testing and appication: laboratory medicine clinical practice guidelines Part1. Lab Med Online. 2016;3: 119-133. https://doi.org/10.3343/lmo.2016.6.3.119
  7. Sim MJ. A study on spatial and a physical environment satisfaction of clinical laboratory scientists, Korean J Clin Lab Sci. 2005;37:111-117.
  8. Choi CD, Kim YA. A study on the laboratory function and spatial organization for laboratory medicine - focused on the tertiary level general hospitals having more than 1000 Beds. Korea Industrial Health Association. 2017;4:37-53. https://doi.org/10.15682/jkiha.2017.23.4.37
  9. Choi CD, Kim YA, Jung TW. A study on the function and work flow of laboratory sections for clinical laboratory design. Korea Industrial Health Association. 2019;1:17-27. https://doi.org/10.15682/jkiha.2019.25.1.17
  10. KCDC. Laboratory biosafety guidelines [Internet]. Osong: KCDC; 2019 [cited 2020 July 9]. Available from: https://www.cdc.go.kr/board.es?mid=a40606010000&bid=0041&act=view&list_no=366952
  11. DHS, CDC, NIH. Biosafety in microbiological and biomedical laboratories, 5th ed. Washington DC: USA Government Printing Office. 2009.
  12. CLSI. Laboratory design: approved guideline, 3rd ed, QMS-04. Wayne, Pennsylvania: CLSI; 2016.
  13. CLSI. Establishing molecular testing in clinical laboratory environments, 1st ed. Wayne, Pennsylvania: CLSI; 2011.
  14. Miller JM, Astles R, Baszler T, Chapin K, Carey R, Garcia L, et al. Guidelines for safe work practices in human and animal medical diagnostic laboratories. Recommendations of a CDC-convened, Biosafety Blue Ribbon Panel. MMWR Suppl. 2012;61:1-102.
  15. WHO. Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases. Interim guidance. Geneva: WHO; 2020 [cited 2020 July 9]. Available from: https://apps.who.int/iris/bitstream/handle/10665/331329/WHO-COVID-19-laboratory-2020.4-eng.pdf
  16. Liu YS, Peng DL, Yang J, Chen D, Jia HB, Yu SY, et al. Laboratory diagnostics within a modular hospital at the time of coronavirus disease 2019 (COVID-19) in Wuhan. Clin Chem Lab Med. 2020;58:1077-1080. https://doi.org/10.1515/cclm-2020-0332
  17. Donna HS. Building a COVID-19 testing LAB [Internet]. Portland: OHSU; 2020 [cited 2021 April 28]. Available from: https://www.onwardohsu.org/blog/detail/building-covid-19-testing-lab
  18. Yang JR, Liu MT, Huang HI, Teng HJ, Chen JH, Li SH. Building the national SARS-CoV-2 laboratory diagnostic capacity in Taiwan. Health Secur. 2020;5:383-391. https://doi.org/10.1089/hs.2020.0056
  19. Kim YA. A Study on the space organization and facility equipment of medical laboratory - focusing on the USA, UK and Germany. Korea Industrial Health Association. 2016;3:7-15. https://doi.org/10.15682/jkiha.2016.22.3.7
  20. KCDC. Guidelines for MERS-CoV control [Internet]. Osong: KCDC; 2015 [cited 2016 Mar 16]. Available from: https://www.ksid.or.kr/mail/file/MERS03.pdf